Background Background There is controversy
There is controversy about whether late-onset schizophrenia about whether late-onset schizophrenia is a precursor of cognitive decline. is a precursor of cognitive decline.
Aims Aims To examine the long-term
To examine the long-term outcome of a group of patients with late-outcome of a group of patients with lateonset schizophrenia. onset schizophrenia.
Method
Method Patients with onset of DSMPatients with onset of DSMÎ II^R schizophrenia at age 50 years or III^R schizophrenia at age 50 years or over, but without dementia, and a healthy over, but without dementia, and a healthy control group were assessed at baseline control group were assessed at baseline ( (n n¼27 and 27 and n n¼34, respectively), after1year 34, respectively), after1year and after 5 years ( and after 5 years (n n¼19 and 19 and n n¼24, 24, respectively) on measures of respectively) on measures of psychopathology, cognition and general psychopathology, cognition and general functioning, and compared on rates of functioning, and compared on rates of decline and incidence of dementia. decline and incidence of dementia.
Results

Results Nine patients with late-onset
Nine patients with late-onset schizophrenia and none of the control schizophrenia and none of the control group were found to have dementia group were found to have dementia (5 Alzheimer type,1vascular, 3 dementia (5 Alzheimer type,1vascular, 3 dementia of unknown type) at 5-year follow-up. of unknown type) at 5-year follow-up. There appeared to be a subgroup of late-There appeared to be a subgroup of lateonset schizophrenia patients without onset schizophrenia patients without signs of dementia at baseline or at1year signs of dementia at baseline or at1year follow-up who subsequently declined. follow-up who subsequently declined.
Conclusions Conclusions Late-onset schizophrenia
Late-onset schizophrenia may be a prodrome of Alzheimer-type may be a prodrome of Alzheimer-type dementia. More longitudinal studies are dementia.More longitudinal studies are required to determine its nosological required to determine its nosological status. status.
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None. Jorgensen, 1985) or normal rates of 'organic deterio-1985) or normal rates of 'organic deterioration', cognitive decline or dementia ration', cognitive decline or dementia (Palmer (Palmer et al et al, 2003) . Limitations of these , 2003). Limitations of these studies of late-onset disease include the studies of late-onset disease include the diversity in schizophrenia diagnoses, the diversity in schizophrenia diagnoses, the lack of standard criteria for dementia diag-lack of standard criteria for dementia diagnosis, and the short duration of follow-up. nosis, and the short duration of follow-up. Whether people with late-onset schizo-Whether people with late-onset schizophrenia, meeting strict criteria, have a high phrenia, meeting strict criteria, have a high risk of developing dementia -and if so, risk of developing dementia -and if so, which type -is of much clinical interest. which type -is of much clinical interest. We have previously reported cross-sec-We have previously reported cross-sectional data on a sample of 27 people with tional data on a sample of 27 people with DSM-III-R-defined schizophrenia (Ameri-DSM-III-R-defined schizophrenia (American Psychiatric Association, 1987) with on-can Psychiatric Association, 1987) with onset of illness at 50 years of age or later set of illness at 50 years of age or later (Brodaty (Brodaty et al et al, 1999; Sachdev , 1999; Sachdev et al et al, 1999 Sachdev et al et al, , , 1999 Sachdev et al et al, , 2000 . The present study reports the 5-year 2000) . The present study reports the 5-year follow-up data on our original sample of follow-up data on our original sample of late-onset schizophrenia patients and nor-late-onset schizophrenia patients and normal controls, including levels of dementia, mal controls, including levels of dementia, current psychosis and functional ability. current psychosis and functional ability.
METHOD METHOD
Sample Sample
Patients with a known diagnosis of late-Patients with a known diagnosis of lateonset schizophrenia were recruited between onset schizophrenia were recruited between 1992 and 1994 from local mental health 1992 and 1994 from local mental health services. The study was approved by several services. The study was approved by several institutional research ethics committees. institutional research ethics committees. After complete description of the study to After complete description of the study to the participants, written informed consent the participants, written informed consent was obtained. All late-onset schizophrenia was obtained. All late-onset schizophrenia patients met DSM-III-R criteria for schizo-patients met DSM-III-R criteria for schizophrenia, as determined independently by phrenia, as determined independently by two psychiatrists using all available data. two psychiatrists using all available data. Late-onset schizophrenia was defined as Late-onset schizophrenia was defined as schizophrenia with age of onset at or after schizophrenia with age of onset at or after the age of 50 years, including the the age of 50 years, including the prodromal phase, as confirmed by an infor-prodromal phase, as confirmed by an informant. Normal controls were volunteers mant. Normal controls were volunteers without a history of psychiatric illness without a history of psychiatric illness recruited through advertisements in senior recruited through advertisements in senior citizens' clubs and older women's citizens' clubs and older women's networks. All participants were White and networks. All participants were White and were competent in the English language. were competent in the English language. The following led to exclusion:
The following led to exclusion:
(a) (a) history of injected drug or alcohol history of injected drug or alcohol misuse of 5 years or more, or of any misuse of 5 years or more, or of any duration within 5 years of the study; duration within 5 years of the study; years, range 50-87), 30 patients with years, range 50-87), 30 patients with early-onset disease (whose results are not early-onset disease (whose results are not included in this paper) and 34 normal con-included in this paper) and 34 normal controls (details described by Brodaty trols (details described by Brodaty et al et al, , 1999) . One late-onset schizophrenia patient 1999). One late-onset schizophrenia patient attained a score of 19 on the MMSE, but attained a score of 19 on the MMSE, but this was considered to be an underestimate. this was considered to be an underestimate. This patient was included in the study, and This patient was included in the study, and scored 23 at reassessment a year later, scored 23 at reassessment a year later, supporting the contention that the poor supporting the contention that the poor initial performance was due to psychosis initial performance was due to psychosis rather than underlying cognitive disorder. rather than underlying cognitive disorder. The psychiatric, neurological, neuro-The psychiatric, neurological, neuropsychological and magnetic resonance psychological and magnetic resonance imaging (MRI) characteristics of the study imaging (MRI) characteristics of the study sample have been reported by Sachdev sample have been reported by Sachdev et et al al (1999, 2000) . (1999, 2000) . The late-onset schizophrenia and nor-The late-onset schizophrenia and normal control groups were comparable on mal control groups were comparable on age, gender and socio-economic status at age, gender and socio-economic status at baseline. However, the patients had baseline. However, the patients had significantly fewer years of education significantly fewer years of education ( (U U z z ¼7 73.48, 3.48, P P¼0.001) and were signifi-0.001) and were significantly more likely to have never been cantly more likely to have never been married ( , 1999). Diagnosis of schizophrenia at 5-year Diagnosis of schizophrenia at 5-year follow-up was based on DSM-IV criteria follow-up was based on DSM-IV criteria (American Psychiatric Association, 1994). (American Psychiatric Association, 1994). Current psychopathological symptoms Current psychopathological symptoms were assessed using the Brief Psychiatric were assessed using the Brief Psychiatric Rating Scale (Overall & Gorham, 1962) , Rating Scale (Overall & Gorham, 1962) , an 18-item scale with each item rated from an 18-item scale with each item rated from 0 (not present) to 6 (extremely severe). 0 (not present) to 6 (extremely severe). Diagnosis of dementia at 5-year follow-up Diagnosis of dementia at 5-year follow-up was based on DSM-IV criteria, using infor-was based on DSM-IV criteria, using information from the CDR, MMSE, Cognitive mation from the CDR, MMSE, Cognitive Decline Scale and items from the CAM-Decline Scale and items from the CAM-DEX. This was reached by consensus in DEX. This was reached by consensus in case conferences involving two psychiatrists case conferences involving two psychiatrists experienced in diagnosing dementia (H.B. experienced in diagnosing dementia (H.B. and P.S.) and a research psychologist. Parti-and P.S.) and a research psychologist. Participants' identifying information was ex-cipants' identifying information was excluded from these conferences. Patients cluded from these conferences. Patients were considered to be diagnosable as were considered to be diagnosable as having mild cognitive impairment at base-having mild cognitive impairment at baseline if their score on the Logical Memory line if their score on the Logical Memory I or II subtest of the Wechsler Memory I or II subtest of the Wechsler Memory Scale (Wechsler, 1981) was 1.5 standard Scale (Wechsler, 1981) was 1.5 standard deviations below the Age Scale score. deviations below the Age Scale score.
Method of follow-up Method of follow-up
Participants were assessed 1 year and 5 Participants were assessed 1 year and 5 years after the baseline investigation. They years after the baseline investigation. They were located by telephone and written were located by telephone and written contact, directly or through their next of contact, directly or through their next of kin, or were traced through the electoral kin, or were traced through the electoral roll (in Australia, registration on the roll (in Australia, registration on the electoral roll is compulsory). Death certifi-electoral roll is compulsory). Death certificates and medical notes were obtained cates and medical notes were obtained where possible for those who had died. where possible for those who had died. Follow-up interviews with participants Follow-up interviews with participants and/or their informants were conducted and/or their informants were conducted by a physician. The next of kin of those by a physician. The next of kin of those who had died were interviewed where who had died were interviewed where possible. possible.
Data analysis Data analysis
The Statistical Package for the Social The Statistical Package for the Social Sciences (SPSS) version 9 for Windows Sciences (SPSS) version 9 for Windows was used for all statistical analyses (SPSS, was used for all statistical analyses (SPSS, 1999) . Two-sample 1999). Two-sample t t-tests were employed -tests were employed for between-group comparisons on con-for between-group comparisons on continuous variables. In the case of IADL, tinuous variables. In the case of IADL, ADL, Cognitive Decline Scale and CDR, ADL, Cognitive Decline Scale and CDR, age differences between the patient and age differences between the patient and control groups approached significance control groups approached significance ( (P P¼0.059), and so age was used as a covari-0.059), and so age was used as a covariate in between-group analyses involving ate in between-group analyses involving these variables. Mann-Whitney these variables. Mann-Whitney U U-tests -tests were used for skewed continuous data. were used for skewed continuous data. Chi-squared analyses were used for be-Chi-squared analyses were used for between-group comparisons on categorical tween-group comparisons on categorical variables. For 2 variables. For 26 62 tables, Yates's continu-2 tables, Yates's continuity correction (denoted by CC ity correction (denoted by CCw w 2 2 ) is re-) is reported. Fisher's exact test was used in the ported. Fisher's exact test was used in the analysis of 2 analysis of 26 62 tables with expected fre-2 tables with expected frequencies lower than 5 in two or more cells. quencies lower than 5 in two or more cells. Change within groups over time on out-Change within groups over time on outcome variables was analysed using repeated come variables was analysed using repeated measures analysis of variance (ANOVA) or measures analysis of variance (ANOVA) or multivariate analysis of variance (MANO-multivariate analysis of variance (MANO-VA). Age at institutionalisation was com-VA). Age at institutionalisation was compared between groups using Kaplan-Meier pared between groups using Kaplan-Meier survival analysis. For all analyses, probabil-survival analysis. For all analyses, probability levels reported were two-tailed, and the ity levels reported were two-tailed, and the level of significance was set at 0.05. level of significance was set at 0.05.
RESULTS
Sample characteristics Sample characteristics
Of the baseline sample of 27 late-onset Of the baseline sample of 27 late-onset schizophrenia patients, 22 (82%) were fol-schizophrenia patients, 22 (82%) were followed up at 1 year, and 19 (70%) were also lowed up at 1 year, and 19 (70%) were also followed up at 5 years, including nine followed up at 5 years, including nine patients who had died and for whom infor-patients who had died and for whom information was provided by an informant. mation was provided by an informant. Causes of death were medical illness in Causes of death were medical illness in eight patients, and an accidental fall in eight patients, and an accidental fall in one patient. Post-mortem examinations one patient. Post-mortem examinations were not carried out. Of the 34 original were not carried out. Of the 34 original healthy controls, 31 (91%) were followed healthy controls, 31 (91%) were followed up at 1 year and 24 (71%) at 5 years. Of up at 1 year and 24 (71%) at 5 years. Of the eight late-onset schizophrenia patients the eight late-onset schizophrenia patients not followed up at 5 years, six could not not followed up at 5 years, six could not be located and two refused. Of the ten con-be located and two refused. Of the ten controls not followed up at 5 years, eight trols not followed up at 5 years, eight refused and two had died. Table 1 com-refused and two had died. Table 1 compares the baseline characteristics of parti-pares the baseline characteristics of participants followed up for 5 years with cipants followed up for 5 years with those not so followed. There was no signif-those not so followed. There was no significant difference between the two sub-icant difference between the two subgroups. Controls who were followed up groups. Controls who were followed up had significantly more years of education had significantly more years of education and lower Hachinski Ischaemia Scale scores and lower Hachinski Ischaemia Scale scores at baseline than those not followed up. at baseline than those not followed up.
Change over 5 years Change over 5 years
On most measures, the patients had a worse On most measures, the patients had a worse outcome after 5 years than did controls outcome after 5 years than did controls ( Table 2 ). They were institutionalised at a ( Table 2 ). They were institutionalised at a younger age, their IADL and ADL scores younger age, their IADL and ADL scores declined more, and their level of cognitive declined more, and their level of cognitive decline, as measured by the CDR and Cog-decline, as measured by the CDR and Cognitive Decline Scale, was significantly worse nitive Decline Scale, was significantly worse than that of controls. Their mean MMSE than that of controls. Their mean MMSE score declined by 6.5 points over 5 years score declined by 6.5 points over 5 years while that of controls remained stable. Of while that of controls remained stable. Of ten patients who were alive at 5-year ten patients who were alive at 5-year follow-up, three patients were not inter-follow-up, three patients were not interviewed. Of the seven who were inter-viewed. Of the seven who were interviewed, one met DSM-IV criterion A for viewed, one met DSM-IV criterion A for schizophrenia at 5-year follow-up, and six schizophrenia at 5-year follow-up, and six out of seven patients assessed with the out of seven patients assessed with the BPRS (including the patient meeting criter-BPRS (including the patient meeting criterion A) had symptoms of psychosis: five ion A) had symptoms of psychosis: five with delusions or hallucinations, one with with delusions or hallucinations, one with grandiose ideation and probable psychosis. grandiose ideation and probable psychosis. Despite decline in other areas, global func-Despite decline in other areas, global functioning (GAF score), while lower than that tioning (GAF score), while lower than that of controls, did not decline in the late-onset of controls, did not decline in the late-onset schizophrenia group as a whole over the schizophrenia group as a whole over the 5-year period. However, patients with 5-year period. However, patients with dementia at 5-year follow-up had a mean dementia at 5-year follow-up had a mean GAF score of 28.1 (s.d. GAF score of 28.1 (s.d.¼19.6, 19.6, n n¼9), in 9), in contrast to a mean GAF of 61.6 contrast to a mean GAF of 61.6 (s.d. (s.d.¼18.9, 18.9, n n¼10) in patients without 10) in patients without dementia at 5 years. The late-onset schizo-dementia at 5 years. The late-onset schizophrenia patients and controls did not differ phrenia patients and controls did not differ significantly in levels of neurological significantly in levels of neurological abnormality at 5-year follow-up. abnormality at 5-year follow-up.
Incidence of dementia Incidence of dementia
At 5-year follow-up we found that nine of At 5-year follow-up we found that nine of the 19 late-onset schizophrenia patients the 19 late-onset schizophrenia patients met DSM-IV criteria for dementia. Five of met DSM-IV criteria for dementia. Five of these met DSM-IV criteria for Alzheimer's these met DSM-IV criteria for Alzheimer's disease and one met criteria for vascular disease and one met criteria for vascular dementia. The remaining three had dementia. The remaining three had dementia of unknown type. None of the dementia of unknown type. None of the controls was found to have dementia. A controls was found to have dementia. A w w 2 2 analysis comparing incidence of any analysis comparing incidence of any dementia between the two groups was dementia between the two groups was highly significant (CC highly significant (CCw , 1975) . The resulting odds ratio of 16.52 1975). The resulting odds ratio of 16.52 had a very wide 95% confidence interval, had a very wide 95% confidence interval, 1.85-147.8, which is not surprising consid-1.85-147.8, which is not surprising considering the zero cell for the control group. ering the zero cell for the control group. If the 'most extreme case scenario' is If the 'most extreme case scenario' is considered and all patients (and controls) considered and all patients (and controls) lost to follow-up did not have dementia, lost to follow-up did not have dementia, the analysis comparing the incidence of de-the analysis comparing the incidence of dementia between the two mentia between the two groups would re-groups would remain highly significant ( main highly significant (w w 2 2 ¼12.8, d.f. 12.8, d.f.¼1, 1, Fisher's exact test Fisher's exact test P P5 50.001). The pseu-0.001). The pseudo-Bayes estimate for the odds ratio is do-Bayes estimate for the odds ratio is 9.98 (95% CI 1.44-69.37). 9.98 (95% CI 1.44-69.37).
Of the 12 patients who had a baseline Of the 12 patients who had a baseline MMSE score of 25 or over, five developed MMSE score of 25 or over, five developed dementia, as did four of seven with initial dementia, as did four of seven with initial MMSE scores below 25. If the rates of de-MMSE scores below 25. If the rates of dementia are calculated only in participants mentia are calculated only in participants whose MMSE scores were 25 or over at whose MMSE scores were 25 or over at baseline, the rate of dementia at follow-up baseline, the rate of dementia at follow-up was still significantly higher in the patients was still significantly higher in the patients than in the controls (5/12 than in the controls ( We conducted We conducted post hoc post hoc comparisons of comparisons of baseline characteristics between late-onset baseline characteristics between late-onset schizophrenia patients who went on to schizophrenia patients who went on to develop dementia ( develop dementia (n n¼9) and those who 9) and those who did not ( did not (n n¼10). Patients who subsequently 10). Patients who subsequently developed dementia were older at baseline, developed dementia were older at baseline, of lower socio-economic status, with longer of lower socio-economic status, with longer duration of illness and with worse IADL, duration of illness and with worse IADL, ADL and MMSE scores than those who ADL and MMSE scores than those who did not develop dementia (Table 3) , but did not develop dementia (Table 3) , but none of these comparisons reached statisti-none of these comparisons reached statistical significance. Re-analysis correcting for cal significance. Re-analysis correcting for age differences did not change these find-age differences did not change these findings. There were non-significant differences ings. There were non-significant differences between the groups on baseline MRI between the groups on baseline MRI variables, with the subsequently demented variables, with the subsequently demented patients having had greater ventricle-to-patients having had greater ventricle-tobrain ratio (see Victoroff Table 3 ).
-weighted imaging ( Table 3) . We examined the influence of possible We examined the influence of possible confounding factors, namely intercurrent confounding factors, namely intercurrent illness and medication usage, on dementia illness and medication usage, on dementia incidence. There was no significant differ-incidence. There was no significant difference between late-onset schizophrenia ence between late-onset schizophrenia patients with and those without dementia patients with and those without dementia as regards occurrence (between the 1-year as regards occurrence (between the 1-year and 5-year assessments) of any of the and 5-year assessments) of any of the following: myocardial infarction, stroke, following: myocardial infarction, stroke, transient ischaemic attack, cerebrovascular transient ischaemic attack, cerebrovascular disease, other neurological changes and sur-disease, other neurological changes and surgery. There was no significant difference gery. There was no significant difference between the two groups in rates of current between the two groups in rates of current usage of psychoactive medications in gener-usage of psychoactive medications in general, or antipsychotics specifically. We did al, or antipsychotics specifically. We did not have sufficient data on history of alco-not have sufficient data on history of alcohol misuse to include it in our analyses, hol misuse to include it in our analyses, but no participant was alcohol-dependent. but no participant was alcohol-dependent. Our study suggests that long-term Our study suggests that long-term follow-up of people with late-onset schizo-follow-up of people with late-onset schizophrenia often yields a picture of progressive phrenia often yields a picture of progressive cognitive decline. Cross-sectional assess-cognitive decline. Cross-sectional assessments in our patients at the time of entry ments in our patients at the time of entry into the study, as reported previously (Sach-into the study, as reported previously (Sachdev dev et al et al, 1999), did not show significant , 1999), did not show significant differences in cognitive function between differences in cognitive function between late-and early-onset schizophrenia, with late-and early-onset schizophrenia, with both diagnostic groups performing worse both diagnostic groups performing worse than healthy individuals. Even at 1-year than healthy individuals. Even at 1-year follow-up (Brodaty follow-up (Brodaty et al et al, 1999) , we did , 1999), we did not see evidence of decline in our late-onset not see evidence of decline in our late-onset schizophrenia sample. The picture was schizophrenia sample. The picture was quite different at 5 years, with high rates quite different at 5 years, with high rates of dementia and institutionalisation. Our of dementia and institutionalisation. Our study supports the findings of Craig & study supports the findings of Craig & Bregman (1988) and Holden (1987) that Bregman (1988) and Holden (1987) that late-onset schizophrenia is a prelude to late-onset schizophrenia is a prelude to dementia in a high proportion of cases. dementia in a high proportion of cases. Holden reported that 13 of 37 patients Holden reported that 13 of 37 patients with a diagnosis of paranoid psychosis, with a diagnosis of paranoid psychosis, and having a minimum score of 21 out of and having a minimum score of 21 out of 43 on a scale of orientation, general knowl-43 on a scale of orientation, general knowledge and memory, progressed to dementia edge and memory, progressed to dementia within 3 years (i.e. 35%, or 11.7% per within 3 years (i.e. 35%, or 11.7% per annum compared with the present rate of annum compared with the present rate of 47.4% over 5 years or 9.5% per annum). 47.4% over 5 years or 9.5% per annum). Palmer Palmer et al et al (2003) did not find evidence (2003) did not find evidence of decline in a group of patients with late-of decline in a group of patients with lateonset schizophrenia-spectrum disorders onset schizophrenia-spectrum disorders over 2 years of follow-up, but conceded over 2 years of follow-up, but conceded that 'longer follow-up periods could reveal that 'longer follow-up periods could reveal that late onset schizophrenia disorder that late onset schizophrenia disorder patients experience a very slow cognitive patients experience a very slow cognitive decline that is obscured by normal practice decline that is obscured by normal practice effects when observed over shorter periods'. effects when observed over shorter periods'. Alternatively, sampling differences might Alternatively, sampling differences might explain the discrepancies in findings. explain the discrepancies in findings.
DISCUSSION
Possible explanations for cognitive Possible explanations for cognitive decline in late-onset schizophrenia decline in late-onset schizophrenia
Our findings do not appear to be a result of Our findings do not appear to be a result of undiagnosed cases of dementia among undiagnosed cases of dementia among participants with late-onset schizophrenia participants with late-onset schizophrenia at baseline, as rates of dementia remained at baseline, as rates of dementia remained 21 6 21 6 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) BPRS score, BPRS score, 8 8 significantly higher when we compared significantly higher when we compared late-onset schizophrenia subsamples with late-onset schizophrenia subsamples with higher index MMSE scores or those with-higher index MMSE scores or those without diagnosable mild cognitive impairment out diagnosable mild cognitive impairment and controls. We were surprised that and controls. We were surprised that dementia cases were predominantly of dementia cases were predominantly of Alzheimer type as evidenced by the Alzheimer type as evidenced by the patient's gradual decline in function, pro-patient's gradual decline in function, prominent disturbance of episodic memory minent disturbance of episodic memory and absence of clinical stigmata of cerebro-and absence of clinical stigmata of cerebrovascular disease. Based on the finding of vascular disease. Based on the finding of increased increased T T 2 2 -weighted hyperintensities in -weighted hyperintensities in the white matter and subcortical nuclei in the white matter and subcortical nuclei in our patients at the start of the study, we our patients at the start of the study, we had predicted an increased incidence of had predicted an increased incidence of vascular dementia. This was not the case, vascular dementia. This was not the case, as judged on a clinical basis. A limitation as judged on a clinical basis. A limitation of our diagnostic process was the absence of our diagnostic process was the absence of neuroimaging at 5-year follow-up, which of neuroimaging at 5-year follow-up, which would have further increased confidence in would have further increased confidence in the diagnosis. It is recognised that sub-the diagnosis. It is recognised that subcortical vascular dementia may present like cortical vascular dementia may present like , 1998) and we cannot rule out this possibility, except we cannot rule out this possibility, except that hypertension was not in excess in the that hypertension was not in excess in the late-onset schizophrenia sample, and these late-onset schizophrenia sample, and these patients' clinical picture was not patients' clinical picture was not characterised by the 'subcortical features' characterised by the 'subcortical features' of psychomotor slowing and frontal of psychomotor slowing and frontal executive deficits. Our participants did not executive deficits. Our participants did not consent to post-mortem examination, consent to post-mortem examination, which was not surprising since they needed which was not surprising since they needed much persuasion at every stage of the study. much persuasion at every stage of the study.
Could psychosis have contributed to the Could psychosis have contributed to the development of Alzheimer's disease in our development of Alzheimer's disease in our study group? Published research such as study group? Published research such as the EURODEM study (Jorm the EURODEM study (Jorm et al et al, 1995) , 1995) on psychiatric risk factors for this disease on psychiatric risk factors for this disease did not find any such association. Nor did not find any such association. Nor was an excess of plaques and tangles found was an excess of plaques and tangles found in a post-mortem study of patients with in a post-mortem study of patients with schizophrenia (Purohit schizophrenia (Purohit et al et al, 1998) . There , 1998). There is also no evidence, after more than 50 is also no evidence, after more than 50 years of their usage, that antipsychotic years of their usage, that antipsychotic agents contribute to the development of agents contribute to the development of dementia (Spohn & Strauss, 1989). One dementia (Spohn & Strauss, 1989). One possible explanation for our finding is that possible explanation for our finding is that we inadvertently included people with early we inadvertently included people with early dementia in our late-onset schizophrenia dementia in our late-onset schizophrenia sample. Even on retrospective review of sample. Even on retrospective review of our early data, the diagnosis of dementia our early data, the diagnosis of dementia was not warranted in any case, at baseline was not warranted in any case, at baseline or at 1-year follow-up. There was, how-or at 1-year follow-up. There was, however, a tendency for those who had demen-ever, a tendency for those who had dementia at 5-year assessment to have had slightly tia at 5-year assessment to have had slightly worse MMSE, ADL and IADL scores at worse MMSE, ADL and IADL scores at baseline. It will be of great clinical interest baseline. It will be of great clinical interest to see whether the patients who were still to see whether the patients who were still cognitively intact at 5 years will also pro-cognitively intact at 5 years will also progress to dementia later in the course of their gress to dementia later in the course of their illness. illness.
Pathogenesis of cognitive decline Pathogenesis of cognitive decline in late-onset schizophrenia in late-onset schizophrenia
The occurrence of a schizophrenia-like The occurrence of a schizophrenia-like psychosis for many years before dementia psychosis for many years before dementia 217 217 becomes manifest warrants speculation on becomes manifest warrants speculation on its pathogenesis. It is parsimonious to argue its pathogenesis. It is parsimonious to argue that late-onset schizophrenia in these cases that late-onset schizophrenia in these cases is a manifestation of changes associated is a manifestation of changes associated with the dementing process. Delusions are with the dementing process. Delusions are common in Alzheimer's disease, but gener-common in Alzheimer's disease, but generally occur in the middle stages of the disease ally occur in the middle stages of the disease rather than being its presenting feature rather than being its presenting feature (Jeste (Jeste et al et al, 1992) . It is possible that in a , 1992). It is possible that in a few patients with Alzheimer's disease the few patients with Alzheimer's disease the brain regions affected in the early stages brain regions affected in the early stages cause a propensity for the development of cause a propensity for the development of psychosis. In particular, lesions of the tem-psychosis. In particular, lesions of the temporal lobes have been implicated (Lewis, poral lobes have been implicated (Lewis, 1995) . We must emphasise that dementia 1995). We must emphasise that dementia did not develop in all our patients, and did not develop in all our patients, and about half of the sample were cognitively about half of the sample were cognitively stable, suggesting that late-onset schizo-stable, suggesting that late-onset schizophrenia is a heterogeneous syndrome. This phrenia is a heterogeneous syndrome. This is further underscored by the clear gulf in is further underscored by the clear gulf in global functioning scores between the global functioning scores between the demented and non-demented patients. demented and non-demented patients. While the mean GAF score of those with While the mean GAF score of those with dementia declined, the mean score of those dementia declined, the mean score of those without dementia rose from 41.4 to 61.6 without dementia rose from 41.4 to 61.6 over the 5 years, which is likely to be due over the 5 years, which is likely to be due to the full or partial resolution of psychosis to the full or partial resolution of psychosis in many cases. The eventual fate of the in many cases. The eventual fate of the non-demented group is, however, of future non-demented group is, however, of future interest. interest.
Implications of the study Implications of the study
Among the strengths of this study were the Among the strengths of this study were the detailed nature of the follow-up assessment, detailed nature of the follow-up assessment, which encompassed information from both which encompassed information from both participants and informants, and the strict participants and informants, and the strict consensus diagnoses of schizophrenia and consensus diagnoses of schizophrenia and dementia using DSM criteria. We were con-dementia using DSM criteria. We were constrained somewhat by the availability of strained somewhat by the availability of informant information only, in cases where informant information only, in cases where the participant had died before the 5-year the participant had died before the 5-year assessment. We were also limited by our assessment. We were also limited by our small sample size and by the level of small sample size and by the level of attrition. However, there was no difference attrition. However, there was no difference at baseline between those followed up and at baseline between those followed up and those not. Although the small sample size those not. Although the small sample size limits the power of this study, it makes limits the power of this study, it makes our finding of a high incidence of dementia our finding of a high incidence of dementia all the more striking. all the more striking.
This study has implications for our This study has implications for our understanding of the presentation and understanding of the presentation and course of schizophrenia and dementia in course of schizophrenia and dementia in the elderly. Further long-term follow-up the elderly. Further long-term follow-up of patients with late-onset schizophrenia, of patients with late-onset schizophrenia, encompassing cognitive measures, func-encompassing cognitive measures, functional neuroimaging and genotyping (e.g. tional neuroimaging and genotyping (e.g. for the apolipoprotein E for the apolipoprotein E e e4 isoform) would 4 isoform) would be of benefit in clarifying the possibility be of benefit in clarifying the possibility that late-onset schizophrenia is an early that late-onset schizophrenia is an early presentation of dementia. Why some presentation of dementia. Why some patients present in this way should then patients present in this way should then become the focus of inquiry. become the focus of inquiry. 
